Tempest Therapeutics, Inc. Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value
Tempest Therapeutics, Inc. (TPST) had Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value of $10.40 million as of 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue · last filed 2018-08-09
- 2018-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $10.40M.
- 2018-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $20.70M.
- 2017-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $22.90M.
- 2017-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $19.50M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value |
|---|---|
| 2018-06-30 | $10.40M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $20.70M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $22.90M 10-Q · filed 2018-08-09 |
| 2017-09-30 | $19.50M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $46.40M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $41.50M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $46.60M 10-K · filed 2018-03-15 |
| 2016-09-30 | $44.90M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $10.80M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $36.10M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $81.40M 10-K · filed 2017-03-02 |
| 2015-09-30 | $54.80M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $60.20M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $13.20M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $44.20M 10-K · filed 2016-02-26 |
| 2014-09-30 | $35.30M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $38.60M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $13.90M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $9.50M 10-K · filed 2015-03-16 |
| 2013-09-30 | $14.70M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $20.20M 10-Q · filed 2013-08-13 |
| 2012-12-31 | $11.60M 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |